Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-11
2005-01-11
Kim, Vickie (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S292000, C514S293000, C514S290000
Reexamination Certificate
active
06841557
ABSTRACT:
The treatment of addictive disorders, psychoactive substance use disorders, intoxication disorders, inhalation disorders, alcohol addiction, tobacco addiction, and nicotine addiction using a heterocyclic amine, a phenylazacycloalkane, a cabergoline, or an aromatic bicyclic amine active agent, or a pharmaceutically acceptable derivative or salt of any said active agent is described herein.
REFERENCES:
patent: 4526892 (1985-07-01), Salvati et al.
patent: 5273975 (1993-12-01), Moon et al.
patent: 5436240 (1995-07-01), Moon et al.
patent: 5462947 (1995-10-01), Svensson et al.
patent: 5594024 (1997-01-01), Svensson et al.
patent: 5877317 (1999-03-01), TenBrink et al.
patent: 6008233 (1999-12-01), Andino et al.
patent: 6448258 (2002-09-01), McCall et al.
patent: 6448293 (2002-09-01), Andrews et al.
patent: 6555548 (2003-04-01), McCall et al.
patent: WO 9015058 (1990-12-01), None
patent: WO 9910339 (1999-03-01), None
patent: WO 9924423 (1999-05-01), None
Caine et al., “D3-receptor test in vitro predicts decreased cocaine self-administreation in rats,”Chem. AbstractXP002168920, 1997.
Calon et al., “Levadopa or D2agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAAreceptors in the striatpallidal complex,”Brain Research 680: 43-52 (1995).
Garner et al., “Analysis of D2and D3Receptor-Selective Ligands in Rats Trained to Discriminate Cocaine from Saline,”Pharmacology, Biochemistry and Behavior 64(2): 373-378 (1999).
Philip L. Gould, “Salt Selection for Basic Drugs, ” International Journal of Pharmaceutics, 33 (1986) pp. 201-217.
Robert E. Hales, M.D., et al., “Nicotine” section, The American Psychiatric Press Textbook of Psychiatry, Second Edition (1994) pp. 401-402.
Richard I. Shader, Chapter 11 “Hypnosis,” Manual of Psychiatric Therapeutics, Second Edition (1994) pp. 81-86.
Anderson Richard W.
Marshall Robert C.
McBrinn Sylvia S.
Robertson David W.
Kim Vickie
Pharmacia & Upjohn
Pharmacia & Upjohn Company
Wootton Thomas A.
LandOfFree
Compounds for the treatment of addictive disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds for the treatment of addictive disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds for the treatment of addictive disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3372595